BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 38113688)

  • 1. A multi-epitope subunit vaccine based on CU/ZN-SOD, OMP31 and BP26 against Brucella melitensis infection in BALB/C mice.
    Wang Y; Wu A; Xu Z; Zhang H; Li H; Fu S; Liu Y; Cui L; Miao Y; Wang Y; Zhumanov K; Xu Y; Sheng J; Yi J; Chen C
    Int Immunopharmacol; 2024 Jan; 127():111351. PubMed ID: 38113688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design of a multi-epitope vaccine candidate against Brucella melitensis.
    Li M; Zhu Y; Niu C; Xie X; Haimiti G; Guo W; Yu M; Chen Z; Ding J; Zhang F
    Sci Rep; 2022 Jun; 12(1):10146. PubMed ID: 35710873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoinformatic-guided designing of multi-epitope vaccine construct against Brucella Suis 1300.
    Jalal K; Khan K; Uddin R
    Immunol Res; 2023 Apr; 71(2):247-266. PubMed ID: 36459272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a multi-epitope peptide vaccine inducing robust T cell responses against brucellosis using immunoinformatics based approaches.
    Saadi M; Karkhah A; Nouri HR
    Infect Genet Evol; 2017 Jul; 51():227-234. PubMed ID: 28411163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design of multi-epitope vaccine candidate against Brucella type IV secretion system (T4SS).
    Yin Z; Li M; Niu C; Yu M; Xie X; Haimiti G; Guo W; Shi J; He Y; Ding J; Zhang F
    PLoS One; 2023; 18(8):e0286358. PubMed ID: 37561685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of immunogenicity of novel multi-epitope subunit vaccines in combination with poly I:C against Brucella melitensis and Brucella abortus infection.
    Sadeghi Z; Fasihi-Ramandi M; Bouzari S
    Int Immunopharmacol; 2019 Oct; 75():105829. PubMed ID: 31437796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of humoral and cellular immune responses to BP26 and OMP31 epitopes in the attenuated Brucella melitensis vaccinated sheep.
    Wang W; Wu J; Qiao J; Weng Y; Zhang H; Liao Q; Qiu J; Chen C; Allain JP; Li C
    Vaccine; 2014 Feb; 32(7):825-33. PubMed ID: 24370708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of potential antigens from non-classically secreted proteins and designing novel multitope peptide vaccine candidate against Brucella melitensis through reverse vaccinology and immunoinformatics approach.
    Vishnu US; Sankarasubramanian J; Gunasekaran P; Rajendhran J
    Infect Genet Evol; 2017 Nov; 55():151-158. PubMed ID: 28919551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccination with the recombinant Brucella outer membrane protein 31 or a derived 27-amino-acid synthetic peptide elicits a CD4+ T helper 1 response that protects against Brucella melitensis infection.
    Cassataro J; Estein SM; Pasquevich KA; Velikovsky CA; de la Barrera S; Bowden R; Fossati CA; Giambartolomei GH
    Infect Immun; 2005 Dec; 73(12):8079-88. PubMed ID: 16299302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design of a new multi-epitope vaccine against
    Chen Z; Zhu Y; Sha T; Li Z; Li Y; Zhang F; Ding J
    Epidemiol Infect; 2021 May; 149():e136. PubMed ID: 34032200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prioritization of potential vaccine candidates and designing a multiepitope-based subunit vaccine against multidrug-resistant Salmonella Typhi str. CT18: A subtractive proteomics and immunoinformatics approach.
    Chand Y; Singh S
    Microb Pathog; 2021 Oct; 159():105150. PubMed ID: 34425197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Immunogenicity of OMP31 Peptides and Its Protection Against Brucella melitensis Infection in Mice.
    Zhang F; Li Z; Jia B; Zhu Y; Pang P; Zhang C; Ding J
    Sci Rep; 2019 Mar; 9(1):3512. PubMed ID: 30837598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and evaluation as vaccines in mice of Brucella melitensis Rev.1 single and double deletion mutants of the bp26 and omp31 genes coding for antigens of diagnostic significance in ovine brucellosis.
    Cloeckaert A; Jacques I; Grilló MJ; Marín CM; Grayon M; Blasco JM; Verger JM
    Vaccine; 2004 Jul; 22(21-22):2827-35. PubMed ID: 15246618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Designing multi-epitope vaccine against important colorectal cancer (CRC) associated pathogens based on immunoinformatics approach.
    Motamedi H; Ari MM; Shahlaei M; Moradi S; Farhadikia P; Alvandi A; Abiri R
    BMC Bioinformatics; 2023 Feb; 24(1):65. PubMed ID: 36829112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design of multi-epitope based vaccine against
    Nayak SS; Sethi G; Ramadas K
    J Biomol Struct Dyn; 2023; 41(23):14116-14134. PubMed ID: 36775659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo immunogenicity assessment and vaccine efficacy evaluation of a chimeric tandem repeat of epitopic region of OMP31 antigen fused to interleukin 2 (IL-2) against Brucella melitensis in BALB/c mice.
    Nazifi N; Tahmoorespur M; Sekhavati MH; Haghparast A; Behroozikhah AM
    BMC Vet Res; 2019 Nov; 15(1):402. PubMed ID: 31703683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Employing an immunoinformatics approach revealed potent multi-epitope based subunit vaccine for lymphocytic choriomeningitis virus.
    Waqas M; Aziz S; Bushra A; Halim SA; Ali A; Ullah S; Khalid A; Abdalla AN; Khan A; Al-Harrasi A
    J Infect Public Health; 2023 Feb; 16(2):214-232. PubMed ID: 36603375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel multi-epitope vaccine against bovine brucellosis: approach from immunoinformatics to expression.
    Rahimnahal S; Yousefizadeh S; Mohammadi Y
    J Biomol Struct Dyn; 2023; 41(24):15460-15484. PubMed ID: 36927475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunological responses and protective efficacy against Brucella melitensis induced by bp26 and omp31 B. melitensis Rev.1 deletion mutants in sheep.
    Jacques I; Verger JM; Laroucau K; Grayon M; Vizcaino N; Peix A; Cortade F; Carreras F; Guilloteau LA
    Vaccine; 2007 Jan; 25(5):794-805. PubMed ID: 17070627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A designed peptide-based vaccine to combat Brucella melitensis, B. suis and B. abortus: Harnessing an epitope mapping and immunoinformatics approach.
    Tarrahimofrad H; Zamani J; Hamblin MR; Darvish M; Mirzaei H
    Biomed Pharmacother; 2022 Nov; 155():113557. PubMed ID: 36115112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.